AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population

To evaluate the safety, efficacy, and patient-reported outcomes of Aquablation therapy using the AQUABEAM Robotic System for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) in a Japanese population. This post-market use-results survey included 103 Japan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of urology 2024-12
Hauptverfasser: Hinata, Nobuyuki, Fujisawa, Masato, Yamaguchi, Raizo, Katsura, Daiki, Kitano, Hiroyuki, Sekino, Yohei, Yoshioka, Kunihiko, Koike, Shin, Odagaki, Yu, Ozawa, Yu, Aoki, Keisuke, Miyauchi, Toshihide, Watanabe, Susumu, Barber, Neil, Elterman, Dean, Afshar, Ali, Saito, Keisuke, Ide, Hisamitsu, Horie, Shigeo
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title International journal of urology
container_volume
creator Hinata, Nobuyuki
Fujisawa, Masato
Yamaguchi, Raizo
Katsura, Daiki
Kitano, Hiroyuki
Sekino, Yohei
Yoshioka, Kunihiko
Koike, Shin
Odagaki, Yu
Ozawa, Yu
Aoki, Keisuke
Miyauchi, Toshihide
Watanabe, Susumu
Barber, Neil
Elterman, Dean
Afshar, Ali
Saito, Keisuke
Ide, Hisamitsu
Horie, Shigeo
description To evaluate the safety, efficacy, and patient-reported outcomes of Aquablation therapy using the AQUABEAM Robotic System for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) in a Japanese population. This post-market use-results survey included 103 Japanese men with BPH who underwent Aquablation across five centers with previously Aquablation naïve physicians. Data were collected at baseline, during the procedure, at discharge, and at 3 and 6 months post-procedure. Key outcomes included International Prostate Symptom Score (IPSS), quality of life (QoL), uroflowmetry parameters, and adverse events. The mean age of patients was 71.1 years, and the average prostate size was 82.3 mL. At 6 months, the mean IPSS significantly improved from 18.1 ± 9.0 to 6.1 ± 5.0 (p 
doi_str_mv 10.1111/iju.15651
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146669083</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3146669083</sourcerecordid><originalsourceid>FETCH-LOGICAL-c175t-81afe52505b02ccdc16d21807f7010cc97eec468783623731cd019990aff82623</originalsourceid><addsrcrecordid>eNo9kc1O3TAQha0KVC60i74A8pIuAv5JnKS7gCgFgWil3nXkOBMwSuLgsVvdN-pj4sulzGakmU9n5ugQ8oWzU57qzD7FU16ogn8gK57nIhMsF3tkxWpeZxUvxQE5RHxijEvBq4_kQNaqZDJXK_Kv-bVuzi-bO-pd54I1FDcYYKIRIfOAcQxIMfo_sPlGm-eou1EH62Y6OE_DI9DgQYcJ5kDdQEf3FzyN3s7ab9JKm5D0piW4CWkfE-1oB7N9mOniHQa9Pfi4WcAvo0arqZ1fRW_0omdAoD_dEncHP5H9QY8In9_6EVl_v_x98SO7vb-6vmhuM8PLIiS3eoBCFKzomDCmN1z1yTMrh5JxZkxdAphcVWUllZCl5KZnvK5rpoehEml0RE52uunB5wgY2smigXFMD7mIreS5UqpmlUzo1x1qkhf0MLSLt1Ny3nLWboNpUzDtazCJPX6Tjd0E_Tv5Pwn5AjyxjBU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146669083</pqid></control><display><type>article</type><title>AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hinata, Nobuyuki ; Fujisawa, Masato ; Yamaguchi, Raizo ; Katsura, Daiki ; Kitano, Hiroyuki ; Sekino, Yohei ; Yoshioka, Kunihiko ; Koike, Shin ; Odagaki, Yu ; Ozawa, Yu ; Aoki, Keisuke ; Miyauchi, Toshihide ; Watanabe, Susumu ; Barber, Neil ; Elterman, Dean ; Afshar, Ali ; Saito, Keisuke ; Ide, Hisamitsu ; Horie, Shigeo</creator><creatorcontrib>Hinata, Nobuyuki ; Fujisawa, Masato ; Yamaguchi, Raizo ; Katsura, Daiki ; Kitano, Hiroyuki ; Sekino, Yohei ; Yoshioka, Kunihiko ; Koike, Shin ; Odagaki, Yu ; Ozawa, Yu ; Aoki, Keisuke ; Miyauchi, Toshihide ; Watanabe, Susumu ; Barber, Neil ; Elterman, Dean ; Afshar, Ali ; Saito, Keisuke ; Ide, Hisamitsu ; Horie, Shigeo</creatorcontrib><description>To evaluate the safety, efficacy, and patient-reported outcomes of Aquablation therapy using the AQUABEAM Robotic System for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) in a Japanese population. This post-market use-results survey included 103 Japanese men with BPH who underwent Aquablation across five centers with previously Aquablation naïve physicians. Data were collected at baseline, during the procedure, at discharge, and at 3 and 6 months post-procedure. Key outcomes included International Prostate Symptom Score (IPSS), quality of life (QoL), uroflowmetry parameters, and adverse events. The mean age of patients was 71.1 years, and the average prostate size was 82.3 mL. At 6 months, the mean IPSS significantly improved from 18.1 ± 9.0 to 6.1 ± 5.0 (p &lt; 0.0001), and QoL scores improved from 4.9 ± 1.3 to 1.8 ± 1.3 (p &lt; 0.0001). Uroflowmetry showed a significant increase in Qmax from 8.3 ± 4.4 to 15.5 ± 7.8 mL/s (p &lt; 0.0001) and a decrease in post-void residual volume (PVR) from 85.6 ± 107.2 to 43.3 ± 60.0 mL (p = 0.0006). At the 30-day primary safety endpoint, there were no reported adverse events of pad-use incontinence, erectile dysfunction, or ejaculatory dysfunction reported, and no device-related serious adverse events were reported. One subject (0.97%) experienced a Clavien-Dindo grade 3 adverse event. Aquablation therapy using the AQUABEAM Robotic System is a reproducible, safe, and effective treatment for Japanese men with BPH, providing significant improvements in LUTS and QoL with a favorable safety profile.</description><identifier>ISSN: 0919-8172</identifier><identifier>ISSN: 1442-2042</identifier><identifier>EISSN: 1442-2042</identifier><identifier>DOI: 10.1111/iju.15651</identifier><identifier>PMID: 39670346</identifier><language>eng</language><publisher>Australia</publisher><ispartof>International journal of urology, 2024-12</ispartof><rights>2024 The Japanese Urological Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c175t-81afe52505b02ccdc16d21807f7010cc97eec468783623731cd019990aff82623</cites><orcidid>0000-0003-1633-784X ; 0000-0001-7014-6812 ; 0000-0003-1507-7783</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39670346$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hinata, Nobuyuki</creatorcontrib><creatorcontrib>Fujisawa, Masato</creatorcontrib><creatorcontrib>Yamaguchi, Raizo</creatorcontrib><creatorcontrib>Katsura, Daiki</creatorcontrib><creatorcontrib>Kitano, Hiroyuki</creatorcontrib><creatorcontrib>Sekino, Yohei</creatorcontrib><creatorcontrib>Yoshioka, Kunihiko</creatorcontrib><creatorcontrib>Koike, Shin</creatorcontrib><creatorcontrib>Odagaki, Yu</creatorcontrib><creatorcontrib>Ozawa, Yu</creatorcontrib><creatorcontrib>Aoki, Keisuke</creatorcontrib><creatorcontrib>Miyauchi, Toshihide</creatorcontrib><creatorcontrib>Watanabe, Susumu</creatorcontrib><creatorcontrib>Barber, Neil</creatorcontrib><creatorcontrib>Elterman, Dean</creatorcontrib><creatorcontrib>Afshar, Ali</creatorcontrib><creatorcontrib>Saito, Keisuke</creatorcontrib><creatorcontrib>Ide, Hisamitsu</creatorcontrib><creatorcontrib>Horie, Shigeo</creatorcontrib><title>AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population</title><title>International journal of urology</title><addtitle>Int J Urol</addtitle><description>To evaluate the safety, efficacy, and patient-reported outcomes of Aquablation therapy using the AQUABEAM Robotic System for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) in a Japanese population. This post-market use-results survey included 103 Japanese men with BPH who underwent Aquablation across five centers with previously Aquablation naïve physicians. Data were collected at baseline, during the procedure, at discharge, and at 3 and 6 months post-procedure. Key outcomes included International Prostate Symptom Score (IPSS), quality of life (QoL), uroflowmetry parameters, and adverse events. The mean age of patients was 71.1 years, and the average prostate size was 82.3 mL. At 6 months, the mean IPSS significantly improved from 18.1 ± 9.0 to 6.1 ± 5.0 (p &lt; 0.0001), and QoL scores improved from 4.9 ± 1.3 to 1.8 ± 1.3 (p &lt; 0.0001). Uroflowmetry showed a significant increase in Qmax from 8.3 ± 4.4 to 15.5 ± 7.8 mL/s (p &lt; 0.0001) and a decrease in post-void residual volume (PVR) from 85.6 ± 107.2 to 43.3 ± 60.0 mL (p = 0.0006). At the 30-day primary safety endpoint, there were no reported adverse events of pad-use incontinence, erectile dysfunction, or ejaculatory dysfunction reported, and no device-related serious adverse events were reported. One subject (0.97%) experienced a Clavien-Dindo grade 3 adverse event. Aquablation therapy using the AQUABEAM Robotic System is a reproducible, safe, and effective treatment for Japanese men with BPH, providing significant improvements in LUTS and QoL with a favorable safety profile.</description><issn>0919-8172</issn><issn>1442-2042</issn><issn>1442-2042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kc1O3TAQha0KVC60i74A8pIuAv5JnKS7gCgFgWil3nXkOBMwSuLgsVvdN-pj4sulzGakmU9n5ugQ8oWzU57qzD7FU16ogn8gK57nIhMsF3tkxWpeZxUvxQE5RHxijEvBq4_kQNaqZDJXK_Kv-bVuzi-bO-pd54I1FDcYYKIRIfOAcQxIMfo_sPlGm-eou1EH62Y6OE_DI9DgQYcJ5kDdQEf3FzyN3s7ab9JKm5D0piW4CWkfE-1oB7N9mOniHQa9Pfi4WcAvo0arqZ1fRW_0omdAoD_dEncHP5H9QY8In9_6EVl_v_x98SO7vb-6vmhuM8PLIiS3eoBCFKzomDCmN1z1yTMrh5JxZkxdAphcVWUllZCl5KZnvK5rpoehEml0RE52uunB5wgY2smigXFMD7mIreS5UqpmlUzo1x1qkhf0MLSLt1Ny3nLWboNpUzDtazCJPX6Tjd0E_Tv5Pwn5AjyxjBU</recordid><startdate>20241213</startdate><enddate>20241213</enddate><creator>Hinata, Nobuyuki</creator><creator>Fujisawa, Masato</creator><creator>Yamaguchi, Raizo</creator><creator>Katsura, Daiki</creator><creator>Kitano, Hiroyuki</creator><creator>Sekino, Yohei</creator><creator>Yoshioka, Kunihiko</creator><creator>Koike, Shin</creator><creator>Odagaki, Yu</creator><creator>Ozawa, Yu</creator><creator>Aoki, Keisuke</creator><creator>Miyauchi, Toshihide</creator><creator>Watanabe, Susumu</creator><creator>Barber, Neil</creator><creator>Elterman, Dean</creator><creator>Afshar, Ali</creator><creator>Saito, Keisuke</creator><creator>Ide, Hisamitsu</creator><creator>Horie, Shigeo</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1633-784X</orcidid><orcidid>https://orcid.org/0000-0001-7014-6812</orcidid><orcidid>https://orcid.org/0000-0003-1507-7783</orcidid></search><sort><creationdate>20241213</creationdate><title>AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population</title><author>Hinata, Nobuyuki ; Fujisawa, Masato ; Yamaguchi, Raizo ; Katsura, Daiki ; Kitano, Hiroyuki ; Sekino, Yohei ; Yoshioka, Kunihiko ; Koike, Shin ; Odagaki, Yu ; Ozawa, Yu ; Aoki, Keisuke ; Miyauchi, Toshihide ; Watanabe, Susumu ; Barber, Neil ; Elterman, Dean ; Afshar, Ali ; Saito, Keisuke ; Ide, Hisamitsu ; Horie, Shigeo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c175t-81afe52505b02ccdc16d21807f7010cc97eec468783623731cd019990aff82623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hinata, Nobuyuki</creatorcontrib><creatorcontrib>Fujisawa, Masato</creatorcontrib><creatorcontrib>Yamaguchi, Raizo</creatorcontrib><creatorcontrib>Katsura, Daiki</creatorcontrib><creatorcontrib>Kitano, Hiroyuki</creatorcontrib><creatorcontrib>Sekino, Yohei</creatorcontrib><creatorcontrib>Yoshioka, Kunihiko</creatorcontrib><creatorcontrib>Koike, Shin</creatorcontrib><creatorcontrib>Odagaki, Yu</creatorcontrib><creatorcontrib>Ozawa, Yu</creatorcontrib><creatorcontrib>Aoki, Keisuke</creatorcontrib><creatorcontrib>Miyauchi, Toshihide</creatorcontrib><creatorcontrib>Watanabe, Susumu</creatorcontrib><creatorcontrib>Barber, Neil</creatorcontrib><creatorcontrib>Elterman, Dean</creatorcontrib><creatorcontrib>Afshar, Ali</creatorcontrib><creatorcontrib>Saito, Keisuke</creatorcontrib><creatorcontrib>Ide, Hisamitsu</creatorcontrib><creatorcontrib>Horie, Shigeo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hinata, Nobuyuki</au><au>Fujisawa, Masato</au><au>Yamaguchi, Raizo</au><au>Katsura, Daiki</au><au>Kitano, Hiroyuki</au><au>Sekino, Yohei</au><au>Yoshioka, Kunihiko</au><au>Koike, Shin</au><au>Odagaki, Yu</au><au>Ozawa, Yu</au><au>Aoki, Keisuke</au><au>Miyauchi, Toshihide</au><au>Watanabe, Susumu</au><au>Barber, Neil</au><au>Elterman, Dean</au><au>Afshar, Ali</au><au>Saito, Keisuke</au><au>Ide, Hisamitsu</au><au>Horie, Shigeo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population</atitle><jtitle>International journal of urology</jtitle><addtitle>Int J Urol</addtitle><date>2024-12-13</date><risdate>2024</risdate><issn>0919-8172</issn><issn>1442-2042</issn><eissn>1442-2042</eissn><abstract>To evaluate the safety, efficacy, and patient-reported outcomes of Aquablation therapy using the AQUABEAM Robotic System for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) in a Japanese population. This post-market use-results survey included 103 Japanese men with BPH who underwent Aquablation across five centers with previously Aquablation naïve physicians. Data were collected at baseline, during the procedure, at discharge, and at 3 and 6 months post-procedure. Key outcomes included International Prostate Symptom Score (IPSS), quality of life (QoL), uroflowmetry parameters, and adverse events. The mean age of patients was 71.1 years, and the average prostate size was 82.3 mL. At 6 months, the mean IPSS significantly improved from 18.1 ± 9.0 to 6.1 ± 5.0 (p &lt; 0.0001), and QoL scores improved from 4.9 ± 1.3 to 1.8 ± 1.3 (p &lt; 0.0001). Uroflowmetry showed a significant increase in Qmax from 8.3 ± 4.4 to 15.5 ± 7.8 mL/s (p &lt; 0.0001) and a decrease in post-void residual volume (PVR) from 85.6 ± 107.2 to 43.3 ± 60.0 mL (p = 0.0006). At the 30-day primary safety endpoint, there were no reported adverse events of pad-use incontinence, erectile dysfunction, or ejaculatory dysfunction reported, and no device-related serious adverse events were reported. One subject (0.97%) experienced a Clavien-Dindo grade 3 adverse event. Aquablation therapy using the AQUABEAM Robotic System is a reproducible, safe, and effective treatment for Japanese men with BPH, providing significant improvements in LUTS and QoL with a favorable safety profile.</abstract><cop>Australia</cop><pmid>39670346</pmid><doi>10.1111/iju.15651</doi><orcidid>https://orcid.org/0000-0003-1633-784X</orcidid><orcidid>https://orcid.org/0000-0001-7014-6812</orcidid><orcidid>https://orcid.org/0000-0003-1507-7783</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0919-8172
ispartof International journal of urology, 2024-12
issn 0919-8172
1442-2042
1442-2042
language eng
recordid cdi_proquest_miscellaneous_3146669083
source Wiley Online Library Journals Frontfile Complete
title AQUABEAM robotic system use-results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T10%3A24%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AQUABEAM%20robotic%20system%20use-results%20survey:%20Aquablation%20for%20the%20treatment%20of%20lower%20urinary%20tract%20symptoms%20due%20to%20benign%20prostatic%20hyperplasia%20in%20the%20Japanese%20Population&rft.jtitle=International%20journal%20of%20urology&rft.au=Hinata,%20Nobuyuki&rft.date=2024-12-13&rft.issn=0919-8172&rft.eissn=1442-2042&rft_id=info:doi/10.1111/iju.15651&rft_dat=%3Cproquest_cross%3E3146669083%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3146669083&rft_id=info:pmid/39670346&rfr_iscdi=true